Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
CMO & EVP Dev & Med Affairs
-
Stock Symbol
-
ALNY on Nasdaq
Pushkal Garg - trading volume in the past year for Alnylam Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
15.7K |
$4.02M |
$255.80 |
Dec 12, 2024 |
Direct |
|
|
Restricted Stock Units |
3.82K |
$603K |
$158.09 |
Feb 27, 2024 |
Direct |
Common Stock |
|
Common Stock |
431 |
$110K |
$255.80 |
Dec 12, 2024 |
by Managed Account |
|
|
Common Stock |
250 |
$64K |
$255.80 |
Dec 12, 2024 |
by Trust |
|
|
Stock Option (right to buy) |
9.28K |
|
|
Mar 1, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.